JP2011510974A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011510974A5 JP2011510974A5 JP2010544844A JP2010544844A JP2011510974A5 JP 2011510974 A5 JP2011510974 A5 JP 2011510974A5 JP 2010544844 A JP2010544844 A JP 2010544844A JP 2010544844 A JP2010544844 A JP 2010544844A JP 2011510974 A5 JP2011510974 A5 JP 2011510974A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- rosuvastatin
- release
- pharmaceutical formulation
- release pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 16
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 claims 14
- 229960000672 rosuvastatin Drugs 0.000 claims 14
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 238000013270 controlled release Methods 0.000 claims 6
- 239000003607 modifier Substances 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 230000037406 food intake Effects 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 208000029578 Muscle disease Diseases 0.000 claims 1
- 206010039020 Rhabdomyolysis Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 231100000417 nephrotoxicity Toxicity 0.000 claims 1
- 230000001839 systemic circulation Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN145KO2008 | 2008-01-30 | ||
| PCT/IN2009/000069 WO2009095934A1 (en) | 2008-01-30 | 2009-01-30 | Modified release formulations of hmg coa reductase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011510974A JP2011510974A (ja) | 2011-04-07 |
| JP2011510974A5 true JP2011510974A5 (https=) | 2012-03-15 |
Family
ID=40638221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010544844A Pending JP2011510974A (ja) | 2008-01-30 | 2009-01-30 | ＨＭＧ−ＣｏＡ還元酵素阻害剤の調節放出製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110003837A1 (https=) |
| EP (1) | EP2285353A1 (https=) |
| JP (1) | JP2011510974A (https=) |
| AU (1) | AU2009208610A1 (https=) |
| BR (1) | BRPI0906728A2 (https=) |
| MX (1) | MX2010008466A (https=) |
| WO (1) | WO2009095934A1 (https=) |
| ZA (1) | ZA201006157B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11590161B2 (en) * | 2018-08-13 | 2023-02-28 | Viscera Labs, Inc. | Therapeutic composition and methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642268B2 (en) * | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| JP2003513036A (ja) * | 1999-11-03 | 2003-04-08 | ハワード ジェイ．スミス アンド アソシエイツ ピーティーワイ リミテッド | 肝臓選択的な治療方法 |
| GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| DE10209979A1 (de) * | 2002-03-07 | 2003-09-25 | Ratiopharm Gmbh | Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung |
| GB0217306D0 (en) * | 2002-07-25 | 2002-09-04 | Novartis Ag | Compositions comprising organic compounds |
| US20050096391A1 (en) * | 2003-10-10 | 2005-05-05 | Per Holm | Compositions comprising fenofibrate and rosuvastatin |
| US8987322B2 (en) * | 2003-11-04 | 2015-03-24 | Circ Pharma Research And Development Limited | Pharmaceutical formulations for carrier-mediated transport statins and uses thereof |
| US20050147620A1 (en) * | 2004-01-05 | 2005-07-07 | Karl Bozicevic | Cinnamon formulation for reducing cholesterol and/or glucose levels |
| WO2007071357A2 (en) * | 2005-12-20 | 2007-06-28 | Lek Pharmaceuticals D.D. | Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid |
-
2009
- 2009-01-30 MX MX2010008466A patent/MX2010008466A/es not_active Application Discontinuation
- 2009-01-30 US US12/865,448 patent/US20110003837A1/en not_active Abandoned
- 2009-01-30 JP JP2010544844A patent/JP2011510974A/ja active Pending
- 2009-01-30 AU AU2009208610A patent/AU2009208610A1/en not_active Abandoned
- 2009-01-30 WO PCT/IN2009/000069 patent/WO2009095934A1/en not_active Ceased
- 2009-01-30 EP EP09706394A patent/EP2285353A1/en not_active Withdrawn
- 2009-01-30 BR BRPI0906728-0A patent/BRPI0906728A2/pt not_active IP Right Cessation
-
2010
- 2010-08-27 ZA ZA2010/06157A patent/ZA201006157B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010518122A5 (https=) | ||
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2016503030A5 (https=) | ||
| FI4406594T3 (fi) | Kilpirauhashormonin analogeja | |
| JP2011502997A5 (https=) | ||
| JP2005515964A5 (https=) | ||
| JP2015524444A5 (https=) | ||
| JP2012502047A5 (https=) | ||
| SI2760821T1 (en) | A salt salt of an anti-inflammatory substituted cyclobutenedione compound | |
| RU2016119746A (ru) | Стабильный состав инсулина глулизин | |
| RU2010109408A (ru) | Композиции с пролонгированным высвобождением, включающие микофенолят натрия, и их действия | |
| FI3541366T3 (fi) | Exendiinin (9-39) puskuroidut formulaatiot | |
| JP2014521641A5 (https=) | ||
| US20140329781A1 (en) | Methods for treating cardiovascular disorder | |
| EP2005962A4 (en) | THERAPEUTIC AGENT FOR INFLAMMATORY ABDOMINAL DISEASE | |
| JP2013508289A5 (https=) | ||
| JP2006514100A5 (https=) | ||
| RU2011152105A (ru) | Составы таблеток 3-цианохинолина и их применение | |
| JP2009507048A5 (https=) | ||
| JP2009522376A5 (https=) | ||
| ES2361284T3 (es) | Combinaciones terapéuticas. | |
| JP2011516544A5 (https=) | ||
| JP2009503097A5 (https=) | ||
| ME02149B (me) | FORMULACIJE l METODE ZA LEČENJE AMILOIDOZE | |
| JP2008088189A5 (https=) |